Pentyl 2-methylisocrotonate
General Information
Chemical name | Pentyl 2-methylisocrotonate |
CAS number | 7785-63-9 |
Flavouring type | substances |
FL No. | 09.680 |
Mixture | No |
Purity of the named substance at least 95% unless otherwise specified | |
Reference body | EFSA |
From webgate.ec.europa.eu
Computed Descriptors
Download SDF2D Structure | |
CID | 82225 |
IUPAC Name | pentyl 2-methylbut-2-enoate |
InChI | InChI=1S/C10H18O2/c1-4-6-7-8-12-10(11)9(3)5-2/h5H,4,6-8H2,1-3H3 |
InChI Key | XJWDRSSGOHXOLQ-UHFFFAOYSA-N |
Canonical SMILES | CCCCCOC(=O)C(=CC)C |
Molecular Formula | C10H18O2 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 170.252 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Complexity | 159.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A D A C g g A I C C A A A B A C I A i D S C A A A A A A A A A A A C A E A A E A A B A I A I Q A C E A A E A A A A I Y C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 26.3 |
Monoisotopic Mass | 170.131 |
Exact Mass | 170.131 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 12 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 1 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9602 |
Human Intestinal Absorption | HIA+ | 0.9951 |
Caco-2 Permeability | Caco2+ | 0.7325 |
P-glycoprotein Substrate | Non-substrate | 0.5924 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7636 |
Non-inhibitor | 0.8435 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8816 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5028 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8737 |
CYP450 2D6 Substrate | Non-substrate | 0.8824 |
CYP450 3A4 Substrate | Non-substrate | 0.5000 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6090 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9262 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9141 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8578 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9055 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6013 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8953 |
Non-inhibitor | 0.8443 | |
AMES Toxicity | Non AMES toxic | 0.8448 |
Carcinogens | Carcinogens | 0.5713 |
Fish Toxicity | High FHMT | 0.7771 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9870 |
Honey Bee Toxicity | High HBT | 0.8486 |
Biodegradation | Ready biodegradable | 0.9711 |
Acute Oral Toxicity | III | 0.8433 |
Carcinogenicity (Three-class) | Non-required | 0.5224 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.5067 | LogS |
Caco-2 Permeability | 1.3287 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.4142 | LD50, mol/kg |
Fish Toxicity | 1.0283 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.7775 | pIGC50, ug/L |
From admetSAR